BAVIS_1170x120_1-20

Valeant Pharmaceuticals International Inc.

L’Oréal buys CeraVe, AcneFree, Ambi brands from Valeant

L’Oréal buys CeraVe, AcneFree, Ambi brands from Valeant

CLICHY, N.Y. — L’Oréal plans to acquire the CeraVe, AcneFree and Ambi skin care brands from Valeant Pharmaceuticals International Inc. for $1.3 billion in cash. Plans call for CeraVe, AcneFree and Ambi to become part of the L’Oréal Active Cosmetics Division, which includes the La Roche-Posay, Vichy and SkinCeuticals brands developed with and endorsed by

Valeant names Perrigo’s Papa as chairman, CEO

Valeant names Perrigo’s Papa as chairman, CEO

NEW YORK — Joseph Papa has resigned as chairman and chief executive officer of Perrigo Co. plc to join Valeant Pharmaceuticals International Inc. as chairman and CEO. Valeant said Monday that Papa, 60, is slated to start at the company by early May. Papa will succeed J. Michael Pearson, who is expected to remain as